A detailed history of Garden State Investment Advisory Services LLC transactions in I Mab stock. As of the latest transaction made, Garden State Investment Advisory Services LLC holds 144,000 shares of IMAB stock, worth $132,480. This represents 0.05% of its overall portfolio holdings.

Number of Shares
144,000
Holding current value
$132,480
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.03 - $1.72 $148,320 - $247,680
144,000 New
144,000 $179 Million

Others Institutions Holding IMAB

About I-Mab


  • Ticker IMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,098,800
  • Market Cap $76.5M
  • Description
  • I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...
More about IMAB
Track This Portfolio

Track Garden State Investment Advisory Services LLC Portfolio

Follow Garden State Investment Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garden State Investment Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Garden State Investment Advisory Services LLC with notifications on news.